Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label Big Pharma. Show all posts
Showing posts with label Big Pharma. Show all posts
Thursday, November 8, 2018

Abbvie has entered into legal action against NHS England over hepatitis C drug program

›
Health Service Journal   NHS England taken to court over 'largest ever medicines procurement'   By Nick Carding 6 November ...
Sunday, April 8, 2018

Putting lives above profits for Hepatitis C treatment

›
Asia: The Star Online Saturday, 7 Apr 2018 Putting lives above profits for Hepatitis C treatment by loh foon fong A HIGHLY effective ...
Monday, March 19, 2018

Prescription Drugs : The Costco Kickbacks

›
Prescription Drugs : The Costco Kickbacks Secret audio tapes and an exclusive television interview with an industry whistleblower reveal a...
Thursday, March 8, 2018

Podcast - Huge pharmaceutical corporations rake in government money

›
Podcast; Huge pharmaceutical corporations rake in government money Listen Here https://www.spreaker.com/user/radiosputnik/huge-pharmaceu...
Wednesday, March 7, 2018

Generic Hepatitis C Drugs Begin to Emerge

›
Recommended Reading Efficacy of Generic Oral Directly Acting Agents in Patients with Hepatitis C Virus Infection. J Viral Hepat. 2018 J...
1 comment:
Wednesday, September 13, 2017

A Gilead-sponsored journey to patient advocacy: ‘[The drug] I would like to promote now is Harvoni’

›
Another ‘breach of trust’ at STAT: patient who praised TV drug ads says pharma PR company asked her to write op-ed Interesting story here ...

Drug Companies Tie Costs to Outcomes

›
Drug Companies Tie Costs to Outcomes By Peter Loftus Sept. 12, 2017 10:07 p.m. ET But early signs show little evidence that the plans...
Monday, September 11, 2017

Janssen to Discontinue Hepatitis C Development Program

›
J&J pulls plug on Medivir-Achillion hep C cocktail to focus on hep B by Ben Adams Why? The same r...
Friday, August 18, 2017

Hepatitis C - Medivir licenses exclusive rights to MIV-802 for Greater China to Ascletis

›
Medivir licenses exclusive rights to MIV-802 for Greater China to Ascletis Stockholm, Sweden and Hangzhou, China— Medivir AB (Nasdaq Stockho...
Saturday, August 5, 2017

AbbVie’s new, cheaper hepatitis C drug could launch the drug world’s own Hunger Games

›
AbbVie’s new, cheaper hepatitis C drug could launch the drug world’s own Hunger Games By Emma Court Published: Aug 5, 2017 10:25 a.m. ...
Thursday, July 27, 2017

Gilead's campaign boosted HCV diagnosis rates for baby boomers

›
Healio -  Industry News Gilead announces continued focus on HBV, HCV, NASH July 26, 2017 During an earnings conference call today, exe...
Friday, July 21, 2017

Perspective for those who want to dig deeper on prescription drug costs

›
Perspective for those who want to dig deeper on prescription drug costs By Scott Scanlon There are many threads to pull when it comes...
Thursday, June 29, 2017

Bloomberg -The Crazy Math Behind Drug Prices

›
The Crazy Math Behind Drug Prices Intermediaries that negotiate to lower prices may cause them to increase, too. By Paul Barrett and Robe...
Saturday, February 25, 2017

Hepatitis C - Big Pharma Quietly Enlists Leading Professors to Justify $1,000-Per-Day Drugs

›
Big Pharma Quietly Enlists Leading Professors to Justify $1,000-Per-Day Drugs by Annie Waldman ProPublica, Feb. 23, 2017, 8 a.m. This ...
Thursday, February 23, 2017

With hep C franchises languishing, Merck’s MK-3682 goes from blockbuster to bomb

›
With hep C franchises languishing, Merck’s MK-3682 goes from blockbuster to bomb by John Carroll A little less than three years after acq...
Tuesday, January 17, 2017

Forbes - The U.S. Government Should Buy Gilead For $156 Billion To Save Money On Hepatitis C

›
The U.S. Government Should Buy Gilead For $156 Billion To Save Money On Hepatitis C Guest post written by Peter B. Bach and Mark Trush...
Thursday, December 29, 2016

This Army Vet Is Fighting Hep C With Big Pharma’s Help

›
This Army Vet Is Fighting Hep C With Big Pharma’s Help by Doni Bloomfield @DoniBloomfield More stories by Doni Bloomfield ‎December‎ ...
Wednesday, November 23, 2016

Settlement reached on state Medicaid denial of pricy hep C drugs

›
Settlement reached on state Medicaid denial of pricy hep C drugs By Molly Rosbach The Health Care Authority on Monday reached a settl...
Wednesday, November 2, 2016

Gilead's Q3 Bombshell: No More Hepatitis C R&D

›
Gilead's Q3 Bombshell: No More Hepatitis C R&D Todd Campbell Nov 2, 2016 at 4:41PM                     ...
Wednesday, September 21, 2016

Surprise: Gilead's hep C wonder Harvoni costs less in U.S. than in EU, Japan

›
Surprise: Gilead's hep C wonder Harvoni costs less in U.S. than in EU, Japan by Tracy Staton It’...